Brain Areas of Time-To-Contact Perception: an Awake Surgery Study (BRAIN-TIME)
Brain Tumors
About this trial
This is an interventional basic science trial for Brain Tumors focused on measuring Time to contact estimation, awake brain surgery, brain tumor, cerebral mapping
Eligibility Criteria
Inclusion Criteria:
For the patients:
- Brain tumor that does not affect the dominant hand motricity. The patient that have a tumor in an area targeted for a cortical stimulation will be automatically enrolled within the Pre-End group.
- Who will agree with all terms and sign the experimental agreement
- Correct or corrected vision, as allowed by the surgery constraints
- With no known oculomotor abnormalities (list of exclusion in Annexe)
- Affiliated to a social security system
For the control group:
- Who will agree with all terms and sign the experimental agreement
- Correct or corrected vision
- With no known oculomotor abnormalities.
- Affiliated to a social security system
Exclusion Criteria:
For the patients:
- Brain tumor located in the occipital area
- Legally protected patient, or with unknown ability to sign the experimental agreement, as determined by the medical team.
- Medical background of neurological diseases of the central nervous system, as Parkinson, Alzheimer, stroke
- Pregnancy
For the control group:
- Legally protected patient, or with unknown ability to sign the experimental agreement, as determined by the medical team.
- Medical background of neurological diseases of the central nervous system, as Parkinson, Alzheimer, stroke
- Pregnancy
Sites / Locations
- University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Patient group
Control group
A total of 120 patients with brain tumors will be divided into our two groups, divided as follows: In the group Pre-Per, 20 patients will be included by localization of electrical stimulation (60 patients in total). A patient who would be stimulable in two different areas could be included in two different groups. In the group Pre-End, the subjects will be distributed by localization of the brain tumor, by lobe. A total of 20 participants will be included per lobe, corresponding to the frontal, temporal or parietal lobes (as a reminder, a tumor in the occipital lobe is an exclusion criterion), for a total of 60 participants
A maximum of 120 healthy matched sex and age subjects with patients will also be included